🦊/Companies

Novian Health

Chicago, US · Delaware corporation · 1 known investors

Find your way into Novian Health

402 people in our graph share verified history with the Novian Health team — schools, employers, funds. One of them is your warm intro.

Imran Bashirunlockedknows Eugene Bajorinas · together at University of Toronto (overlapped)
×3knows the team · via University of Illinois Urbana-Champaign
×2knows the team · via UC Irvine
knows the team · via The University of Chicago Booth School of Business
knows the team · via Norton Healthcare
×4knows the team · via The University of Kansas

Novian Health develops Novilase, a minimally invasive laser ablation system for treating breast tumors (both malignant and benign) as an alternative to surgery. The device has received FDA 510(k) clearance for benign breast tumors and CE Mark approval in Europe, with clinical trials underway for early-stage breast cancer treatment.

Founders & leadership

DK
Dr. Kambiz DowlatFounder
JRJohn Regan
John ReganinActing CFO & Board MemberJohn Regan is Managing Partner of T2G Ventures, a venture advisory firm, and serves as a board member at Novian Health. He has 25+ years of experience in venture capital investing and innovation across healthcare, IT, and software, previously leading Illinois Ventures and Energy Foundry, and has served on boards of companies including CDnow and EnvestNet.
EBEugene Bajorinas
Eugene BajorinasinVice President OperationsEugene Bajorinas is Vice President of Operations at Novian Health, where he oversees operations, clinical development, and commercialization of Novilase, an ultrasound-guided laser ablation platform for breast tumors. He brings prior experience launching and scaling healthcare services, building healthcare brands, and supporting regulatory and clinical development initiatives for medical devices.
HA
Henry AppelbaumPresident, Chief Executive Officer, and Director
WGWilliam Graveman
William GravemaninVice PresidentWilliam Graveman spent 10 years in component and systems engineering at Bendix Corporation and over 20 years designing and manufacturing automobile shredding and processing equipment before transitioning to medical device design, development, and regulatory affairs. He has expertise in medical device prototyping, manufacturing, tissue ablation, and clinical trial activities.

Board

ALAnthony Lacenere
Anthony LacenereBoard directorSenior Managing Partner at iNetworks
ATAnthony Tomasello
Anthony TomaselloinChairmanEmeritus Senior Managing Partner at iNetworks
CG
Charles GordonBoard director
SB
Stephen BonnerBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$19.8M disclosed across 2 rounds · 2021–2024

$5.3MraisedMar 2026 · 28 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles GordonDirector
  • Anthony LacenereDirector
  • John ReganExecutive Officer, Director
  • Eugene BajorinasExecutive Officer
  • Stephen BonnerDirector
  • Henry AppelbaumExecutive Officer, Director
  • William GravemanExecutive Officer
Offering amount
$10M
Amount sold
$5.3M
Sales commissions
$57.8K
Placement agents
B. Riley Wealth Management, Inc., Alliance Global Partners, LLC
First sale
Jan 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$14.4MraisedDec 2021 · 92 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Eugene BajorinasExecutive Officer
  • William GravemanExecutive Officer
  • John ReganDirector
  • Anthony LacenereDirector
  • Stephen BonnerDirector
  • Anthony TomaselloDirector
  • Henry AppelbaumExecutive Officer, Director
Offering amount
$19.8M
Amount sold
$14.4M
Minimum investment
$25K
Sales commissions
$932.3K
Proceeds to insiders
$1M
Placement agents
National Securities Corporation
First sale
Jul 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

What does Novian Health do?
Novian Health develops Novilase, a minimally invasive laser ablation system for treating breast tumors (both malignant and benign) as an alternative to surgery. The device has received FDA 510(k) clearance for benign breast tumors and CE Mark approval in Europe, with clinical trials underway for early-stage breast cancer treatment.
Who founded Novian Health?
Novian Health was founded by Dr. Kambiz Dowlat.
Who are Novian Health's investors?
Novian Health's investors include iNetworks.
How much funding has Novian Health raised?
Novian Health has disclosed $19.8M raised across 2 rounds.
Where is Novian Health headquartered?
Novian Health is headquartered in Chicago, US.